{"issuance_frequency":"","notes_translated":{"fr":"On considère qu'un produit antiseptique est un produit qui inactive, réduit, prévient ou freine la croissance des microorganismes avec l'intention inhérente d'atténuer ou de prévenir la maladie. La présente ligne directrice présente des recommandations concernant l'information que Santé Canada juge nécessaire afin d'appuyer ces types d'allégations.","en":"An antiseptic product is considered to be one that inactivates, reduces, prevents or arrests growth of microorganisms with the inherent intent to mitigate or prevent disease. This guidance document provides recommendations regarding the information considered necessary by Health Canada in order to support these types of claims."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"eaf41db2-edd7-47e7-b0ba-24be1607a293","metadata_created":"2021-06-01T17:11:47.310606","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-06-01T17:11:47.310612","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-06-01","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["document d'orientation","usage humain","médicaments antiseptiques","inactive ou arrête la croissance des micro-organismes","atténue ou prévient la maladie"],"en":["guidance document","human-use","antiseptic drugs","inactivates or arrests growth of microorganisms","mitigate or prevent disease"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Ligne directrice - médicaments antiseptiques à usage humain","en":"Guidance Document - Human-Use Antiseptic Drugs"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"eaf41db2-edd7-47e7-b0ba-24be1607a293","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"3586a3da-3a80-4c1a-82a7-009ddcd3a96d","related_relationship":"","name_translated":{"fr":"Ligne directrice - médicaments antiseptiques à usage humain","en":"Guidance Document - Human-Use Antiseptic Drugs"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance Document - Human-Use Antiseptic Drugs","language":["en"],"created":"2021-06-01T17:11:47.391431","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/human-use-antiseptic-drugs.html#a1","last_modified":null,"position":0,"revision_id":"1dadc0cf-82b4-49ff-8959-6298db284929","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"eaf41db2-edd7-47e7-b0ba-24be1607a293","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1ddca463-1814-47b6-9ef4-a98ac6cc8768","related_relationship":"","name_translated":{"fr":"Ligne directrice - médicaments antiseptiques à usage humain","en":"Guidance Document - Human-Use Antiseptic Drugs"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance Document - Human-Use Antiseptic Drugs","language":["fr"],"created":"2021-06-01T17:11:47.391437","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/medicaments-antiseptiques-usage-humain.html#a1","last_modified":null,"position":1,"revision_id":"1dadc0cf-82b4-49ff-8959-6298db284929","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2019-11-15 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"eaf41db2-edd7-47e7-b0ba-24be1607a293","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"An antiseptic product is considered to be one that inactivates, reduces, prevents or arrests growth of microorganisms with the inherent intent to mitigate or prevent disease. This guidance document provides recommendations regarding the information considered necessary by Health Canada in order to support these types of claims.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Guidance Document - Human-Use Antiseptic Drugs","revision_id":"1dadc0cf-82b4-49ff-8959-6298db284929"}